Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 1, 2004, Pages 112-117

  Miwa, H ^a   Minoo, T ^a   Hojo, M ^a   Yaginuma, R ^a   Nagahara, A ^a   Kawabe, M ^a   Ohkawa, A ^a   Asaoka, D ^a   Kurosawa, A ^a   Ohkusa, T ^a   Sato, N ^a,b  

^a JUNTENDO UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BARRETT ESOPHAGUS; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERSENSITIVITY; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STIMULUS RESPONSE; STOMACH EROSION;

EID: 4344682976     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01990.x     Document Type: Conference Paper

References (38)

1. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-9.
2. Venables TL, Newland RD, Patel AC, Hole J, Copeman MB, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965-73.
3. Fass R, Ofman JJ. Gastroesophageal reflux disease-Should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97(8): 1901-9.
4. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-45.
5. Shi G, Brulry des Varannes S, Scarpignato C, et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-64.
6. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
7. Kamolz T, Velanovich V. Psychological and emotional aspects of gastroesophageal reflux disease. Dis Esophagus 2002; 15; 199-203.
8. Bradley LA, Richter JE, Pulliam TJ, et al. The relationship between stress and symptoms of gastroesophageal reflux: The influence of psychological factors. Am J Gastroenterol 1993; 88: 11-9.
9. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction; a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001: 281: G743-51.
10. Fass R, Yalam JM, Camargo L, Johnson C, Garewal HS, Sampliner RE. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrette's esophagus. Dig Dis Sci 1997; 42: 1853-8.
11. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
12. Jones RH, Pali A, Hungin S, et al. Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings. Eur J General Pract 1995; 1: 149-54.
13. Hoshihara Y. Endoscopic diagnosis and classification of GERD. In: Tsuneoka, K, ed. Clinical Significance of GERD (GERD No Rinsyo to Konnnichiteki Igi). Tokyo. Medical Review Co., Ltd, 1999; 62-8. (In Japanese.)
14. Arima N. A study of the incidence of GERD in human day dock. Ther Res 2002; 23: 1003-6. (In Japanese.)
15. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Int GORD Study Group Eur J Gastroenterol Hepatol 1998; 10: 119-24.
16. Lind T, Havelund T, Lundell L, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without esophagitis - a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999; 13: 907-14.
17. Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 1958; 34: 760-81.
18. Graham DY, Patterson DJ. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 1983; 28: 559-63.
19. Winnan GR, Meyer CT, Mccallum RW. Interpretation of the Bernstein test, a reappraisal of criteria. Ann Intern Med 1982; 96: 320-2.
20. Winwood PJ, Mavrogiannis CC, Smith CL. Reduced sensitivity to intra-oesophageal acid in patients with reflux-induced strictures. Scand J Gastroenterol 1993; 28: 109-12.
21. Shi G, Tatum RP, Joehl RJ, Kahrilas PJ. Esophageal sensitivity and symptom perception in gastroesophageal reflux disease. Curr Gastroenterol Rep 1999; 1: 214-9.
22. Sami R, Achem. Endoscopy-negative gastroesophageal reflux disease. Gastroenterol Clin North Am 1999; 28: 893-904.
23. Kurosawa A, Miwa H, Hirai S, et al. Decreased expression of tight junction protein and increased cell proliferation in the esophageal mucosa in the endoscopy negative gastroesophageal reflux disease. Gastroenterology 2002; 122: A418 (Abstract).
24. Smith JL, Opekun AR, Larkai E, et al. Sensitivity of the esophageal mucosa to pH in esophageal reflux disease. Gastroenterology 1989; 96: 683-9.
25. Fass R, Higa L, Kondner A. et al. Chronic mucosal inflammation of the esophagus in gastroesophageal reflux disease. Gastroenterology 1996; 110: A662 (Abstract).
26. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GERD. Gut 1995; 37: 7-12.
27. Howard PJ, Maher L, Pryde A, et al. Symptomatic gastrooesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 128-32.
28. Trimble KC, Douglas S, Pryde A, Heading RC. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995; 40: 1098-104.
29. Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-esophageal reflux disease. Scand J Gastroenterol 1986; 21: 837-47.
30. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease. a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997; 11: 765-73.
31. Voutilainen M, Sipponen P, Mecklin J, Juhola M, Färkkilä M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13.
32. Behar J, Biancani P, Sheahan DG. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 1976; 71: 9-15.
33. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
34. Robinson M, Earnest D, Rodriguez-Stanley S, et al. Heartburn requiring frequent antacid may indicate significant illness. Arch Intern Med 1998; 158: 2373-6.
35. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-45.
36. Wu JCY, Sung JJY, Chan FKL, et al. Helicobactor pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 427-32.
37. Wu JC, Chan FK, Ching JY, Leung WK, Lee YT, Sung JJ. Empirical treatment based on 'typical' reflux symptom is inappropriate in a population with a high prevalence of Helicobactor pylori infection. Gastrointest Endosc 2002; 55: 461-5.
38. Chan CC, Lee CI, Wu CH. Twenty-four-hour ambulatory esophageal pH monitoring in patients with symptoms of gastroesophageal reflux, J Formos Med Assoc 1997; 96: 874-8.